semaglutide cardiovascular outcomes news #VisualAbstract: and in Obesity without Diabetes New Science Suggests Semaglutide Improves

What the Research Says About GLP-1s and HS While clinical research is still in early stages, several studies support what many of us in the HS community have seen anecdotally: A 2024 study of patients with HS found that semaglutide reduced the frequency of flares and systemic inflammationflaring decreased from once every 8.5 weeks to once every 12 weeks

Pain and IBD: The Contributing Role of Diet and Nutrition

Once this interaction is disrupted: p53 is released from the nucleus Cellular self-destruction pathways are activated Senescent cells undergo apoptosis This selective mechanism has made FOXO4-DRI one of the most studied senolytic peptides in modern aging research

Moreover, the percentage of mean changes scores were significantly different between the two groups in frailty status and hand grip test